MedPath

Effects of Moxibustion on Gastrointestinal Cancer-Related Fatigue: A Randomized, Controlled Trial

Phase 1
Conditions
Gastrointestinal Cancer-Related Fatigue
Registration Number
ITMCTR2200006572
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Meet the diagnostic criteria for gastric cancer and colorectal cancer, TNM staging is II to III; meet the diagnostic criteria for cancer-related fatigue(CRF), fatigue occurs after the diagnosis of gastric cancer and colorectal cancer, and is related to the cancer itself or cancer-related treatment;
2) Ages range from 18 to 70 years old;
3) ECOG score = 2 points;
4) BFI-C=4 points;
5) Estimated survival period = 6 months;
6) The patient has never received acupuncture or moxibustion within the first 3 months of enrollment;
7) No mental or intellectual abnormality, able to understand the provisions of various scales and complete the assessment;
8) Agree to participate in this study and sign the written informed consent.

Exclusion Criteria

1) Those who are highly suspected of malignant tumor but cannot find the primary tumor;
2) Suffering from major physical diseases, such as serious diseases of the heart, liver, kidney, etc.;
3) Life expectancy is less than 6 months, or bedridden;
4) Pregnant or lactating patients;
5) Symptomatic mental illness and mental disorders, patients who cannot communicate normally due to drug addiction, alcohol addiction, abuse of psychotropic substances, etc.;
6) There are ulcers, abscesses, skin infections, etc. at the moxibustion site;
7) Patients who have received moxibustion therapy due to fatigue in the past 1 month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with a reduction of =3 points on the Brief Fatigue Index (BFI-C) score;
Secondary Outcome Measures
NameTimeMethod
Brief Fatigue Index (BFI-C);Generalized Anxiety Disorder Scale (GAD-7);Quality of Life Questionnaire (QLQ-C30);Blood test;Serum T lymphocyte subsets;
© Copyright 2025. All Rights Reserved by MedPath